SCHEMBL22658398

SCHEMBL22658398

CON(C)C(=O)C(F)(F)c1cccc(NC(=O)O)c1

nearest known ligand 0.50

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
TP53 P04637 1/20 0.50
SMN1; SMN2 Q16637 3/20 0.47
MAPT P10636 5/20 0.46
MEN1 O00255 4/20 0.46
KMT2A Q03164 4/20 0.46
RAB9A P51151 2/20 0.46
HTT P42858 1/20 0.46
ALDH1A1 P00352 3/20 0.45
LMNA P02545 3/20 0.45
GAA P10253 3/20 0.45
L3MBTL1 Q9Y468 1/20 0.45
RXFP1 Q9HBX9 1/20 0.43
NPSR1 Q6W5P4 2/20 0.43
HSP90AA1 P07900 1/20 0.43
PKM P14618 1/20 0.43
XBP1 P17861 1/20 0.43
POLB P06746 1/20 0.43
KDM4E B2RXH2 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22670292 0.85 RXFP1 (0.52) TP53SMN1; SMN2MAPTMEN1KMT2A
SCHEMBL29467538 0.81 RAB9A (0.55) TP53SMN1; SMN2MAPTRAB9AHTT
SCHEMBL25007307 0.80 PTPN5 (0.48)
SCHEMBL30222787 0.80 PTPN5 (0.48)
SCHEMBL22670274 0.78 TSHR (0.46) TP53SMN1; SMN2ALDH1A1NPSR1
SCHEMBL29433296 0.78 TSHR (0.46) TP53SMN1; SMN2ALDH1A1NPSR1
SCHEMBL25006865 0.78 RIPK1 (0.41) MAPTMEN1KMT2ARAB9AHTT
SCHEMBL30222838 0.78 RIPK1 (0.41) MAPTMEN1KMT2ARAB9AHTT
SCHEMBL17925886 0.75 MEN1 (0.57) TP53SMN1; SMN2MAPTMEN1KMT2A
SCHEMBL2096025 0.75 MAPT (0.75) TP53SMN1; SMN2MAPTMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3983386-A1 ACSS2 INHIBITORS AND METHODS OF USE THEREOF Metabomed Ltd (IL) 2022-04-20 EP disclosed
WO-2020230136-A1 ACSS2 INHIBITORS AND METHODS OF USE THEREOF METABOMED LTD (IL) 2020-11-19 WO disclosed